Reverse Genetics To Forward The Pan-Lassa Fever Vaccine Lead Candidate ML29

Project: Other project

Project Details

StatusFinished
Effective start/end date8/1/18 → 7/31/20

Funding

  • National Inst of Allergy & Infectious Di: $739,589.41